Friday, May 27, 2016 10:15:53 AM
"There is zero question that NNVC is paying TheraCour to do what they do. However it is my understanding that employees who develop products and processes for pay automatically assign the rights to that IP to their employer."
However, mike41 seems like he has an excellent understanding of trade secrets in manufacturing, and it seems like he understands that NNVC owns that valuable asset.
I'm still not sure either way, but I tend to believe mike41, with his apparent industry experience.
Overall, it's not that important to me who owns the know-how.
As long as NNVC can sell antiviral drugs (owing just 15% of their gross sales as a royalty to Theracour), it's a good deal to me. Say NNVC develops their own sales force to sell hypothetically $100M/year of their eye antiviral drug. NNVC would keep $85M/year, and owe $15M to Theracour. If NNVC sublicenses on very generous terms and gets 50% of $100M sales, then Theracour gets 15% of that $50M, or $7.5M, with NNVC keeping the remaining 85%, or $42.5M.
Who would care at that point that the drugs cost $63M to develop over 11 years - if they brought in $40-$100s of M per year in profit for just one of them?
BTW, I'm still not sure if it's 15% of NNVCs take (CEO indication) or 15% of total sales (seems to be the language in the license). This would be important if NNVC sublicenses out to big pharma and keeps only a cut of sales, say 20-50%.
The license agreement says:
"2.3 TheraCour retains the exclusive right to develop and manufacture the aforesaid drugs. As to any Licensed Product, TheraCour agrees that it will manufacture such drug exclusively for Nano, and unless such license is terminated, will not manufacture such product for its own sake or for others. Nano agrees that TheraCour shall automatically have a license to employ Nano’s proprietary or patented technologies or other know how for the purpose of manufacturing the drug as may be required without payment of any consideration therefore, whether cash or non-cash considerations, irrespective of whether such consideration is with or without monetary value."
So if NNVC developed some manufacturing know-how, they would apparently own it and Theracour could use it. If Theracour develops it for NNVC's behalf and NNVC pays for it, does Theracour still own it? Perhaps, but then again, it's still a good deal for NNVC if it brings in decent sales.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM